To compare the incidence of post operative nausea and vomiting using neostigmine and sugammadex as a reversal agent

Efficacy of Sugammadex versus Neostigmine on post operative nausea and vomiting after general anaesthesia in adult patients: a randomised control trial - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085259

Enrollment

136

Registered

2025-04-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Sugammadex as a Reversal Agent After General Anesthesia.: Sugammadex 4mg/kg body weight will be given as reversal agent after surgery follwed by which prophylactic Ondansetron 8mg iv w

Eligibility

Inclusion criteria

Inclusion criteria: All ASA-1 and ASA-2 patients not coming under exclusion criteria

Exclusion criteria

Exclusion criteria: Pregnancy and Breastfeeding Mothers Neuromuscular Disorders Significant Hepatic And Renal Impairement

Design outcomes

Primary

Measure	Time frame
To Compare the Incidence of PONV between both the drugs within the first 24 hours of Post Operative periodTimepoint: 24 hours	—

Secondary

Measure	Time frame
To Compare the Clinical Parametres of RecoveryTimepoint: 1 HOUR	—

Countries

India

Contacts

Public ContactDr Ratulbir Goyal

Kalinga Institute of Medical Sciences

2387017@kims.ac.in7008016886

Outcome results